Retail media will reach $60.81 billion in 2025—adding more new dollars than Meta and Alphabet combined—and brands now rank incrementality as a top KPI. In this interview, Tinuiti’s Elizabeth Marsten lays out how to prove incremental sales, pick smarter tools, and keep measurement future-ready.
Nvidia woos global AI partners, HP shifts output to Mexico and Vietnam, and Lenovo pivots to India—clear signs that risk mitigation now outweighs China’s diminishing cost advantage.
Issuers and POS providers need to offer fast, secure checkout experiences.
Kohl’s beat Q1 expectations, but challenges remain: The struggling retailer is focused on improving its assortment, establishing value and quality leadership, and offering a seamless customer experience.
Consumers want to redeem rewards for travel, making a seamless booking interface a smart choice for any bank
Jack Dorsey’s company is committed to expanding its crypto offerings, but their utility remains dubious.
The era of tariff-driven trade uncertainty is far from over: A flurry of legal decisions have thrown the administration’s trade policies into limbo, even as many duties remain firmly in place.
E.l.f. Beauty strikes $1 billion deal to acquire Hailey Bieber’s Rhode: The move could reignite slowing growth and boost its appeal to Gen Z and more affluent shoppers.
Best Buy will stick to its tariff playbook despite court rulings: The retailer is doing its best to ignore the noise and focus on how best to serve its customers.
Potential tariffs, drug pricing order may not be too disruptive to pharma: However, the administration’s executive orders, proposals, and threats can’t be taken lightly. Drug companies must stay nimble with plans in place for different outcomes.
Trump administration drops Moderna mRNA pandemic flu research: This adds to increasing doubt around the validity of mRNA vaccines, and will likely cause uncertainty for drugmakers looking to federal agencies for vaccine guidance.
Senate leader questions pharma advertising oversight amid growing calls for more regulation: The threats of new legislation and regulations indicate the seriousness of both the Trump administration and Congress to move against pharma ads.
Healthcare costs for Americans who have employer-sponsored health insurance spike 7% annually: Employers will need to be more restrictive with their plan offerings, creating an opportunity for D2C healthcare brands to reel in new customers.
Most consumers divide their time across gaming, music, podcasts, and social, but streaming remains on top—even as mobile becomes the default for short- and long-form video.
Prime Video offers show-level ad reporting: The move positions it as a testing ground for streaming’s evolution, where transparency matters as much as viewer data.
Fubo debuts biddable pause ads: The move is the first time a CTV platform has offered biddable pause ads, but will require rapid scaling to remain effective.
Adobe’s new Email Designer addresses content delays with cloning, GenStudio integration, and improved reuse—streamlining production for time-starved teams.
Post analytics and custom button tracking signal LinkedIn’s push to compete with TikTok and Instagram for creator attention.